FDA NDC Directory · JSON-LD · Markdown

VITRAKVI

NDC 50419-392 · HUMAN PRESCRIPTION DRUG · SOLUTION, CONCENTRATE

Generic nameLAROTRECTINIB
Labeler / ManufacturerBayer HealthCare Pharmaceuticals Inc.
Marketing categoryNew Drug Application (innovator) · App NDA211710
Dosage form / routeSOLUTION, CONCENTRATE · OROPHARYNGEAL
Active ingredientsLAROTRECTINIB (20 mg/mL)
Marketing started20190726
Package count1

External sources

Source: openFDA. Public-domain (CC0).